Equibles does not estimate personal net worth.
Get an email with a short summary when Neumora Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get NMRA alertsBill Aurora is recorded as COO at Neumora Therapeutics, Inc. (NMRA) since February 14, 2025. Neumora Therapeutics, Inc. reported in an 8-K filed February 13, 2025 that Bill Aurora was appointed Chief Operating and Development Officer, effective February 14, 2025. The proxy statement of Neumora Therapeutics, Inc. reports total compensation of $3,302,000 for Bill Aurora in fiscal 2025, including a base salary of $545,000. Disclosed compensation is on record for 3 fiscal years. Bill Aurora has spoken on 1 earnings call across 1 company, most recently for Neumora Therapeutics, Inc. on March 30, 2026. Neumora Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Neumora Therapeutics, Inc. includes Joshua Pinto (CEO and Board Member), Paul L. Berns (CEO, Chairman and Board Member), Michael Milligan (CFO) and 7 others.
“Bill Aurora, Pharm.D. will transition from the role of Chief Strategy Officer to Chief Operating and Development Officer”
“We are excited about the data from NMRA 511, which demonstrated a differentiated profile for the treatment of agitation in Alzheimer's disease. In January, we shared top-line results from our Phase 1B signal-seeking study of 5.11.”
2025-02-14–present
Source not stated
Biotechnology · Healthcare
COO
2025-02-14–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Neumora Therapeutics, Inc. (NMRA) | Pharm.D. Chief Strategy Officer | $545,000 | $3,302,000 |
| 2024 | Neumora Therapeutics, Inc. (NMRA) | Pharm.D. Chief Strategy Officer | $496,787 | $5,201,926 |
| 2023 | Neumora Therapeutics, Inc. (NMRA) | Pharm.D. Chief Strategy Officer | $473,130 | $3,179,845 |
